A Multi-Center, Open Label, Single Group, Observational Study to Investigate the Effects of Training on the Administration of Cardioplexol™
This is a multi-center, open label, single group, observational study designed to evaluate the effects of a Cardioplexol™ preparation and administration training program proposed to cardiac surgeons and cardiotechnicians inexperienced in the use of Cardioplexol™.
The training program aims at increasing the efficacy of Cardioplexol administration while reducing the risk of false manipulations. During the training possible risks and consequences of incorrect applications as well as the measures to take in case of administration error, are discussed. The training program includes one standardized theoretical part and one practical part consisting of a direct intra-operative coaching of surgeons practicing their first 2 operations.
The effect of the training will then be assessed by evaluating each trained surgeon's 4 next consecutive patients operated with Cardioplexol and without the coach.
/ Not yet recruitingPhase 3 A multi-center, open label, single group, observational study to investigate the effects of training on the administration of Cardioplexol (TM)?
/ Not yet recruitingPhase 3 A Single-Centre, Single Blind, Randomized, Active-Controlled Phase III Non-Inferiority Study to Investigate the Safety and Efficacy of the Cardioplegic Solution Cardioplexol? when used during a Cardiac Surgical Intervention under the Assistance of a Heart-Lung Machine
100 Clinical Results associated with Swiss Cardio Technologies AG
0 Patents (Medical) associated with Swiss Cardio Technologies AG
100 Deals associated with Swiss Cardio Technologies AG
100 Translational Medicine associated with Swiss Cardio Technologies AG